Literature DB >> 1321455

Glycogen storage disease diagnosed in adults.

J S Pears1, R T Jung, D Hopwood, I D Waddell, A Burchell.   

Abstract

Glycogen storage diseases are usually identified in childhood. We present the clinical, biochemical and histological features of 10 patients first diagnosed in adult life. Five had glycogen storage disease type 1a, one type 1c, two type IX, and in two patients there were previously unreported abnormalities of hepatic glucose-6-phosphatase system activity. Of the latter, one patient had an inhibitor of liver glucose-6-phosphatase (pseudo-1b glycogen storage disease) the other having abnormal glucose-6-phosphatase activity and microsomal pyrophosphate transport. A glucagon test is suggested as a useful screening procedure. Glycogen storage disease should be considered in adults with symptoms suggesting hypoglycaemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321455

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  7 in total

1.  Therapeutic insulin and hepatic glucose-6-phosphatase activity in preterm infants.

Authors:  A Burchell; A McGeechan; R Hume
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

2.  Abnormal expression of glucose-6-phosphatase in preterm infants.

Authors:  R Hume; A Burchell
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

3.  Immunohistochemical localisation of glucose-6-phosphatase in developing human kidney.

Authors:  R Hume; J E Bell; A Hallas; A Burchell
Journal:  Histochemistry       Date:  1994-07

4.  Multiple transport protein defects in a patient with glycogen storage disease type 1: GSD 1b/1c beta.

Authors:  R A Hawkins; K R Kamath; H M Scott; A Burchell
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  The human embryonic-fetal kidney endoplasmic reticulum phosphate-pyrophosphate transport protein.

Authors:  R Hume; H Brewerton; A Burchell
Journal:  Virchows Arch       Date:  1996-03       Impact factor: 4.064

6.  Fatty acyl-CoA esters inhibit glucose-6-phosphatase in rat liver microsomes.

Authors:  R Fulceri; A Gamberucci; H M Scott; R Giunti; A Burchell; A Benedetti
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

7.  Characterization of the mutations in the glucose-6-phosphatase gene in Israeli patients with glycogen storage disease type 1a: R83C in six Jews and a novel V166G mutation in a Muslim Arab.

Authors:  R Parvari; S Moses; E Hershkovitz; R Carmi; N Bashan
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.